|
|
|
42
|
58652
|
VFEND 200MG INJ (PFI) VORICONAZOLE
|
VORICONAZOLE
|
VFEND
|
100ML
|
C
|
311.68
|
311.68
|
VIAL
|
28
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081492
|
ANTIFUNGALS, MISCELLANEOUS
|
2026-04-01
|
|
|
IV
|
0
|
ANTIFUNGALS, MISCELLANEOUS
|
|
|
|
|
40
|
58654
|
VORIOLE 200MG INJ (MSN/ATB) VORICONAZOLE
|
VORICONAZOLE
|
VORIOLE
|
200MG VIAL
|
BQ
|
40.77
|
40.77
|
INJECTION
|
0
|
VIAL
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081408
|
AZOLES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
58811
|
GLUCOBAY 50MG TAB (BSP/COL) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.40
|
0.22
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58811
|
GLUCOBAY 50MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.4
|
0.2191
|
TAB
|
180
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2024-07-25
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-06-13
|
|
|
|
40
|
58816
|
GLUCOBAY 50MG TAB (BSP/AHI) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.40
|
0.22
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
5881J
|
ACARBOSE 50MG TAB (RYV/ATB)
|
ACARBOSE
|
ACARBOSE
|
90'S
|
C
|
16.17
|
0.18
|
TABLET
|
180
|
TAB
|
RYV
|
RYVIS PHARMA PVT. LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
5881N
|
GLUCAR 50MG TAB (GLP) ACARBOSE (C)
|
ACARBOSE
|
GLUCAR
|
100'S
|
C
|
1.71
|
0.02
|
TAB
|
180
|
BLIS
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
|
|
|
|
40
|
58821
|
GLUCOBAY 100MG TAB (BSP/COL) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.40
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58821
|
GLUCOBAY 100MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.3975
|
TAB
|
90
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2024-07-25
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-06-13
|
|
|
|
40
|
58824
|
GLUCOBAY 100MG TAB (BSP/AHI) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.40
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58824
|
GLUCOBAY 100MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.3975
|
TAB
|
90
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
|
|
|
|
40
|
5882G
|
ACARBOSE 100MG TAB (LDP/AHI)
|
ACARBOSE
|
ACARBOSE
|
84'S
|
C
|
24.06
|
0.29
|
TABLET
|
0
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
5921H
|
DANAZOL 200MG TAB (CIP/AHI)
|
DANAZOL
|
DANAZOL
|
100'S
|
C
|
645.85
|
6.46
|
TABLET
|
0
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6808
|
ANDROGENS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-03-29
|
|
|
|
42
|
5921L
|
DANOGEN 200MG CAP (CIP) DANAZOL
|
DANAZOL
|
DANOGEN
|
10X10
|
C
|
223.75
|
2.24
|
CAP
|
30
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6808
|
ANDROGENS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANDROGENS
|
|
|
|
|
40
|
59311
|
PROCORALAN 5MG TAB (SER/STO) IVABRADINE
|
IVABRADINE
|
PROCORALAN
|
28'S
|
C
|
60.87
|
2.17
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2022-04-06
|
2024-03-31
|
Package Size Change
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
2022-04-06
|
|
|
|
40
|
59314
|
PROCORALAN 5MG TAB (SER/COL) IVABRADINE
|
IVABRADINE
|
PROCORALAN
|
28'S
|
C
|
60.87
|
2.17
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2022-04-13
|
2024-03-31
|
Add to Contract as Cat C
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
2022-04-13
|
|
|
|
40
|
59319
|
PROCOROLAN 5MG TAB (SER/COL) IVABRADINE
|
IVABRADINE
|
PROCOROLAN
|
56'S
|
C
|
121.73
|
2.17
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
59319
|
PROCOROLAN 5MG TAB (SER) IVABRADINE (C)
|
IVABRADINE
|
PROCOROLAN
|
56'S
|
C
|
109.09
|
1.948
|
TAB
|
0
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CARDIAC DRUGS MISCELLANEOUS
|
|
|
|
|
42
|
59319
|
PROCOROLAN 5MG TAB (SER) IVABRADINE
|
IVABRADINE
|
PROCOROLAN
|
56'S
|
C
|
109.09
|
1.95
|
TAB
|
0
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
AVENTA BARBADOS
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CARDIAC DRUGS MISCELLANEOUS
|
|
|
|
|
40
|
5931A
|
PROCORLAN 5MG TAB (SER/STO) IVABRADINE
|
IVABRADINE
|
PROCORLAN
|
56'S
|
C
|
121.73
|
2.17
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
240492
|
CARDIAC DRUGS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
